nach oben

Applied Health Economics and Health Policy

Erschienen in:

01.08.2017 | Commentary

We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs

verfasst von: Anna Månsdotter, Björn Ekman, Inna Feldman, Lars Hagberg, Anna-Karin Hurtig, Lars Lindholm

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Excerpt

Monitoring and evaluation within the area of social welfare and public health comprise theoretical and methodological challenges [1, 2]. Indeed, current approaches may fail to consider essential aspects and to capture the broad spectrum of beneficial impacts from interventions. Therefore, we propose a novel measure taking into consideration the concept of capabilities: capability-adjusted life-years (CALYs). This commentary suggests principles, reflecting the Swedish context, to build the measure on. Of course, years of empirical research and refinement remain. …

Rosén M, Lindholm L. The neglected effects of lifestyle interventions in cost-effectiveness analysis. Health Promot Int. 1992;7:163–9.CrossRef

Weatherly H, Drummond M, Claxton K, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009;93:85–92.CrossRefPubMed

Hurley J. An overview of the normative economics in the health sector. In: Culyer AJ, Newhouse JP, editors. Handbook of health economics. Amsterdam: Elsevier; 2000. p. 55–118.

Sen A. Rational fools. Philosophy and Public Affairs. 1977;6(4):317–44.

Sen A. Capabilities and commodities. Amsterdam: Elsevier; 1985.

Nussbaum M. Women and human development: the capabilities approach. Cambridge New York: Cambridge University Press; 2000.CrossRef

Cookson R. QALYs and the capability approach. Health Econ. 2005;14:817–29.CrossRefPubMed

EuroQol Group. http://www.euroqol.org/. Accessed 29 Mar 2017.

Brouwer W, Culyer A, van Exel J, Rutten F. Welfarism vs extra-welfarism. J Health Econ. 2008;27:325–38.CrossRefPubMed

10.

Al-Janabi H, Flynn TN, Coast J. Development of a self-report measure of capability wellbeing for adults: the ICECAP-A. Qual Life Res. 2012;21:167–76.CrossRefPubMed

11.

Flynn TN, Huynh E, Peters TJ, Al-Janabi H, Clemens S, Moody A, Coast J. Scoring the Icecap-a capability instrument. Estimation of a UK general population tariff. Health Econ. 2015;24(3):258–69.CrossRefPubMed

12.

Mitchell M, Roberts T, Barton P, Coast J. Assessing sufficient capability: a new approach to economic evaluation. Soc Sci Med. 2015;139:71–9.CrossRefPubMed

13.

SOU. Får vi det bättre? Om mått på livskvalitet. [Are we better off? On measures of quality of life]. Swedish Governmental Public Investigations. 2015;56.

14.

Daniels N. Just health: meeting health needs fairly. New York: Cambridge University Press; 2008.

15.

Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–108.CrossRefPubMed

16.

Sen A. Development as freedom. Oxford New York: Oxford University Press; 1997.

17.

Forte [Swedish Research Council for Health, Working life and Welfare]. Är en bättre folkhälsa värd sitt pris? - En hälsoekonomisk utvärdering av ökad bemanning inom hemtjänsten [Is improved public health worth its costs? A health economic evaluation of increased staffing in home care]. Research grant, No 2015-00647. 2015.

18.

Coast J, Kinghorn P, Mitchell P. The development of capability measures in health economics: opportunities, challenges and progress. Patient. 2015;8:119–26.CrossRefPubMed

19.

Månsdotter A, Ekman B, Feldman I, Hagberg L, Hurtig A-K, Lindholm L. Towards capability-adjusted life-years (CALYs) in public health and social welfare: results from a pilot study on ranking capabilities. 2017 (in preparation).

20.

Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012;380:2129–43.CrossRefPubMed

21.

Burström K, Sun S, Gerdtham U, Henriksson M, Johannesson M, Levin L-Å, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–42.CrossRefPubMed

22.

Williams A. Intergeneration equity: an exploration of the “fair innings” argument. Health Econ. 1997;6:117–32.CrossRefPubMed

23.

Culyer A. Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use. Health Econ Policy Law. 2016;11:415–32. doi:10.1017/S1744133116000049.CrossRefPubMed

24.

Lorgelly P, Lorimer K, Fenwick E, Briggs A, Anand P. Operationalising the capability approach as an outcome measure in public health: the development of the OCAP-18. Soc Sci Med. 2015;142:68–81.CrossRefPubMed

25.

Drummond MF, Schulper M, Torrance G, O’Brien B, Stoddart G. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 2005.

26.

Lindholm L. Goda år—ett nytt mått för utvärdering av välfärdsinsatser. [Good years—a novel measure for evaluating welfare policies]. Application to the Umeå Board for Ethical Clearance (EPN), Protocol No 2017/57-31.

Titel: We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs
verfasst von: Anna Månsdotter
Björn Ekman
Inna Feldman
Lars Hagberg
Anna-Karin Hurtig
Lars Lindholm
Publikationsdatum: 01.08.2017
Verlag: Springer International Publishing
Erschienen in: Applied Health Economics and Health Policy / Ausgabe 4/2017
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI: https://doi.org/10.1007/s40258-017-0323-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance

A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?

Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy

Drug Pricing in South Korea

Comment on: “Measuring the Volume–Outcome Relation for Complex Hospital Surgery”

Clinical, Economic and Policy Implications of Drug Shortages in the European Union